Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

Share Price is delayed by 15 minutes
Get Live Data
15.50    0.00 (0.00%)
Bid:
14.10
Ask:
16.90
Spread: 2.80 (19.858%)
Market Cap: £12.51m
LMS Live PriceLast checked at - London Stock Exchange

Intraday Lms Capital Share Chart

Publication Announcement

2 Jun 2009 16:10

RNS Number : 1901T
LMS Capital PLC
02 June 2009
 



LMS Capital plc

This document is not a prospectus. Investors should not subscribe for any transferable securities referred to in this announcement except on the basis of information in the prospectus.

This announcement is not for release, publication or distribution in or into the united states, australia, Canada, japan or south africa

2 June 2009

LMS Capital plc, ("LMS Capital" or the "Company"), a self-managed closed-ended international investment company, today announces the proposed migration of its ordinary shares (the "Shares") from the London Stock Exchange's AIM market to the Official List of the UK Listing Authority (the "Official List") and the Main Market of the London Stock Exchange. The Company has today published its prospectus, which is available for public inspection on the Company's website and at the Viewing Facility of the UK Listing AuthorityJ.P. Morgan Cazenove Limited has been appointed as Sponsor and Financial Adviser in connection with the Admission, and is acting as NOMAD in relation to the de-listing from AIM

The Board believes that the Company, having gained valuable experience as a public company admitted to AIM since June 2006, has now developed and matured sufficiently as a company for the Main Market to be the most appropriate platform for the Company's continued growth. The Board believes that a listing on the Official List and admission to the Main Market will have the following benefits for Shareholders

The Main Market represents a larger pool of capital, offering investors greater liquidity;

The Company will have a potentially broader investor base as the inclusion of the Company in one of the FTSE's Indices will open the Shares up to tracker investors;

The Company's profile will be raised through greater market making participation and research analyst coverage;

Shareholders will have access to a more frequent and more detailed understanding of the Company's activities as a result of interim management statements and other disclosure requirements resulting from the Main Market's more expansive regime; and

Investors may also invest in the Shares through ISAs.

It is expected that the admission of the Company's shares to the Official List and to trading on the Main Market of the London Stock Exchange will take place simultaneously with the de-listing from AIM, and will become effective at 08:00 on Tuesday 30th June 2009.

A copy of the prospectus has been submitted for public inspection at the Document Viewing Facility of the UK Listing Authority, The Financial Services Authority, 25 The North Colonnade, Canary Wharf, London E14 5HS.

 

For further information, please contact:

Robert Rayne, Chief Executive Officer

Martin Pexton, Managing Director

Tony Sweet, Chief Financial Officer

LMS Capital plc

+44 (0)20 7935 3555

Michael Wentworth-Stanley 

William Simmonds

J.P. Morgan Cazenove Limited

+44(0)20 7588 2828

Simon Sporborg 

Robin Tozer

Brunswick Group

+44(0)20 7404 5959

This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities of LMS Capital plc in any jurisdiction. No offer of securities of LMS Capital plc is being, or will be, made to the public. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about, and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein is not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Australia, Canada, Japan or South Africa or any jurisdiction in which such distribution or publication is unlawful.

This announcement is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or an exemption from registration. No public offering of securities will be made in the United States by the Company in connection with the Company's admission to the Official List and the the Main Market of the London Stock Exchange.

The price of securities and the income from them may go down as well as up and investors may not get back the full amount invested on disposal of the securities. There is no guarantee that the market price of securities in LMS Capital plc will fully reflect their underlying net asset value.

Notes for Editors

About LMS Capital (www.lmscapital.com)

LMS Capital is an international investment company. The investment portfolio comprises investments primarily in the US and the UK, with a spread of early stage revenue-generating technology investments, development capital and mature company buyouts.

The following tables provide summary details of the Company's portfolio as at 30 April 20091.

 

Top 25 Investments (Excluding fund interests in which the Company has only a minority position)

Rank (% of NAV)

Investment

Geography

Type ofInvestment

Date of initialinvestment

Cost £m

BookValue£m

Effectiveequity interest

% of LMSCapital'snetassets

1

Weatherford International Ltd

US

Quoted

2001

19,923

22,901

9%

2

Method products

US

Fund portfolio

2004

6,308

21,487

13%

9%

3

Prostrakan Group plc

UK

Quoted

1999

23,717

13,729

8.7%

6%

4

Rave Reviews Cinemas

US

Unquoted

2002

6,406

6,406

13%

3%

5

Cityspace Limited

UK

Unquoted

1997

21,357

6,000

94%

2%

6

Wesupply Limited

UK

Unquoted

2000

18,886

5,500

99%

2%

7

Penguin Computing

US

Fund portfolio

2004

5,088

5,498

19%

2%

8

Gulfmark Offshore Inc

US

Quoted

2008

6,689

4,525

2%

9

Luxury Link

US

Fund portfolio

2006

2,460

4,143

14%

2%

10

Coppereye Limited

UK

Unquoted

2001

12,711

3,981

76%

2%

11

Elateral Limited

UK

Unquoted

2000

7,160

3,500

40%

1%

12

Healthcare Management Systems Inc

US

Unquoted

2007

2,471

3,365

8%

1%

13

Chyron Corporation

US

Quoted

1995

1,438

3,054

17.8%

1%

14

Entuity Limited

UK

Unquoted

2000

10,757

3,000

68%

1%

15

Venture Production plc

UK

Quoted

2007

2,370

2,810

1%

16

Yes To, Inc

US

Fund portfolio

2008

2,499

2,657

11%

1%

17

Pims Group

UK

Unquoted

2008

2,905

2,500

10%

1%

18

BJ Services

US

Quoted

2007

3,627

2,333

1%

19

Telespree Communications

US

Unquoted

1999

3,830

2,185

25%

1%

20

7 Global Limited

UK

Unquoted

2000

20,026

2,000

91%

1%

21

Vio Worldwide Limited

UK

Unquoted

2002

20,350

2,000

84%

1%

22

The Guild

US

Fund portfolio

2006

5,332

2,104

40%

1%

23

Offshore Tool and Energy Corp.

US

Unquoted

1998

12,768

1,976

100%

1%

24

Envestnet Asset Management

US

Unquoted

2001

1,537

1,537

1%

1%

25

Eye-Fi

US

Unquoted

2008

1,005

1,368

5%

1%

(1) This information is based on the latest audited valuatuion of the Company's investment portfolio (as at 31 December 2008) with adjustments in the four months ended 30 April 2009 for (a) price movements in quoted securities, (b) movements in foreign currency exchange rates, (c) cash calls and distributions from funds, and (d) purchases and sales of quoted securities.  In addition where the Company has invested further amounts in the existing unquoted portfolio, these amounts have been written off as fair value adjustments in the period pending the next full valuation of the portfolio scheduled for 30 June 2009. Investments in new unquoted securities are included at cost pending the next full valuation of the portfolio as at 30 June 2009. 

 

Total Portfolio

Sector

%

Value (£m)

Applied technology 

28

59.4

Media and leisure

26

54.9

Energy and water

19

40.7

Healthcare and medical

10

19.8

Real estate

8

16.6

Other

9

18.8

Total

100

210.2

 

Total Portfolio

Asset Type and Geography

%

Value (£m)

US

Funds

36

75.4

Quoted

17

34.6

Unquoted

8

17.5

Sub-total 

61

127.5

UK

UK Funds

14

30.4

UK Quoted

9

18.7

UK Unquoted

16

33.6

Sub-total 

39

82.7

Total

100

210.2

Vintage2

Type of investment

Total Portfolio

Quoted

Unquoted

Funds

%

Value (£m)

2008-9

4.7

4.3

0.8

5

9.8

2006-7

6.5

6.2

24.2

17

36.9

2004-5

1.5

0.2

51.1

25

52.8

Older

40.6

40.4

29.7

53

110.7

Total

53.3

51.1

105.8

100

210.2

(2"Vintage" means the year the Company first invested into the relevant investment. 

Valuation basis

Total Portfolio

%

Value (£m)

3

Third Party Valuation

57

118.9

Public Market Quotation

25

53.3

Directors' valuation

18

38.0

Total

100

210.2

(3) Third party valuation includes valuation reports from fund managers regarding the Company's fund positions and co-investments.

Future Commitments

As at 30 April 2009, the Company had the following outstanding commitments in respect of its fund investments:

 

Future Commitments

Total Portfolio

 

%

Value (£m)

US Funds

53

38.7

UK Funds

47

34.4

Total

100

73.1

The commitments to US funds are denominated in US dollars and at 30 April 2009 amounted to $57.4 million; the amount has been converted to pounds sterling at a rate of £1.00: US $1.49 (being the prevailing exchange rate as at 30 April 2009). Included in the commitments to US funds is $15.6 million in respect of San Francisco Equity Partners.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEANKAEDDNEEE
Date   Source Headline
13th May 20263:32 pmRNSResults of 2026 Annual General Meeting
24th Apr 20263:37 pmRNSTR‑1: Notification of Major Holdings
24th Apr 20267:00 amRNSFirst Quarter 2026 Update
17th Apr 20261:09 pmRNSNotice of Annual General Meeting
19th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
17th Feb 202612:37 pmRNSTR‑1: Notification of Major Holdings
16th Feb 20267:00 amRNSCompany Update and Unaudited Net Asset Value
13th Jan 20267:00 amRNSSecond Return of Capital
4th Nov 20257:00 amRNS3rd Quarter Trading Update
8th Oct 20259:30 amRNSChange of Auditor
11th Aug 20257:01 amRNSHalf-year Report
11th Aug 20257:00 amRNSInvestment in Dacian
15th Jul 20253:21 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSStatement re B Share issue
15th May 202510:23 amRNSResult of AGM & GM
14th May 20253:01 pmRNSResult of AGM & GM
14th May 20257:00 amRNSAGM Statement
24th Apr 202510:43 amRNSNotice of GM Broadcast
24th Apr 202510:36 amRNSNotice of GM
22nd Apr 20257:00 amRNS1st Quarter Results
8th Apr 20251:47 pmRNSNotice of AGM Broadcast
8th Apr 20251:34 pmRNSNotice of AGM
28th Mar 20257:00 amRNSFinal Results
17th Mar 20259:07 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSStatement re proposed managed realisation
25th Feb 20251:27 pmRNSHolding(s) in Company
19th Feb 20258:44 amRNSHolding(s) in Company
13th Feb 20257:00 amRNSNet Asset Value(s)
20th Dec 20249:22 amRNSDirector/PDMR Shareholding
13th Nov 20244:32 pmRNSCompany Secretary Change
18th Oct 20247:00 amRNSThird Quarter 2024 Update
5th Sep 20243:49 pmRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSSenior Independent Director Appointment
31st Jul 20247:00 amRNSHalf-year Report
15th Jul 20247:00 amRNSUpdate on Investment
16th May 20244:54 pmRNSResult of AGM and Dividend Declaration
15th May 20247:00 amRNSDirectorate Change
8th May 20249:19 amRNS1st Quarter Results
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.